First trial of antiviral monkeypox drug that could speed recovery begins in UK

Clinical trial will explore whether Tecovirimat can reduce time it takes for skin lesions and ulcers to heal

The first clinical trial in patients with monkeypox of an antiviral drug that could speed their recovery has begun in the UK.

The trial, known as Platinum, will explore whether Tecovirimat may reduce the length of time it takes for skin lesions and ulcers to heal.

Continue reading…

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments